The Louisiana Legislature passed a bill on May 23, 2024, that reclassify two abortion pillsMifepristone and misoprostol, as “controlled, dangerous substances.” Both pills have long been used safely and effectively in medical abortions and to treat miscarriages and other conditions. The bill, which is predicted to be signed by the state’s governor, makes it illegal to own either pill and not using a prescription. Surgical and medical Abortions are already banned in Louisiana, with few exceptions.
The Conversation US asked twin sisters Jamie Rowana legal scholar and Tami Rowenan obstetrician-gynecologist, explains the impact of the brand new law – for each patients and providers.
What does Louisiana law say regarding these abortion pills?
Mifepristone and misoprostol have long been considered uncontrolled substances. Although a prescription is required to acquire these drugs, there have been no criminal consequences for possession of those drugs.
Louisiana's recent bill would reclassify the pills as Schedule 4 drugs if passed. These include medications comparable to diazepam, higher referred to as Valium, and tramadol, a commonly used opioid.
In the United States, pharmaceuticals are divided into two categories: uncontrolled and controlled. These are based on the likelihood of psychological and physical dependence on the drug. Louisiana just upgraded the 2 drugs from “non-controlled” to “controlled.”
A prescription is already required to access medication abortion throughout the United States, so under Louisiana's recent law, women searching for abortions will still need a prescription to get the pills, just as they do now.
What this law primarily does is make possession of the pills against the law for individuals who don’t need an abortion. In Louisiana, it is prohibited to have a medical or surgical abortion without the death of the lady or “significant and irreversible physical impairment.” Louisiana residents seeking a medication abortion must obtain the pills from outside the state. Under this new law, if someone transports or stores mifepristone or misoprostol in Louisiana without a valid prescription, You could also be confronted A jail sentence of between one and five years and a wonderful of as much as $5,000 could also be imposed.
Controlled substances are further categorised by list. Under federal law, the list names are separated by a Abuse potential of the drugits risk to public health and another aspects.
Under Louisiana law, there are five schedules which follow similar categorizations to federal law. A Schedule 4 classification implies that the drug or other substance has a low potential for abuse, has a currently accepted medical use, and that abuse of the drug or other substance can lead to limited physical or psychological dependence.
By classifying mifepristone and misoprostol as Schedule 4 controlled drugs, the legislature is claiming, without evidence, that there are risks of dependence and abuse related to taking these drugs.
On what scientific evidence, if any, did the legislator base his decision?
This is the primary time a state has classified abortion drugs as a controlled substance, but an unprecedented classification of abortion drugs as Schedule 4 drugs will not be expected.
Taiwan Mifepristone is classed similarly This way.
However, the classification has no scientific basis, as no studies indicate that the drug carries a risk of addiction or abuse. Mifepristone will be used for abortion, the treatment of miscarriages and even for Induction of laborBe more practical than conventional treatments with misoprostol alone.
In terms of safety, it is beneficial to match the risks of mifepristone with one other commonly used drug, Viagra. Although Viagra is prescription only, unclassified as a controlled substance. For mifepristone, there are rare reported cases of nonspecific fatal sepsis This might be related to women within the US who’ve a medical abortion
In contrast, Viagra was linked to 1,473 serious hostile events and 522 reported deaths within the United States during a 13-month period. Louisiana's legislative history doesn’t explain the science behind this classification system.
It must be noted that no risk of dependency of misoprostol or mifepristone. Misoprostol has been approved by the Food and Drug Administration for its ability to alleviate the symptoms of stomach ulcers, but is widespread in all areas of obstetrics and gynecology to induce labor and stop postpartum bleeding. Side effects for those, who Misoprostol for ulcers or gynecological care are rare, especially in comparison with other medicinal products in Schedule 4.
AP Photo/Jose Luis Magana
How might the brand new law affect access to non-abortion procedures?
Under the brand new law, penalties of as much as five years in prison will be imposed no matter whether the pills are intended for an individual having an abortion or attempting to induce a miscarriage. In addition, the law doesn’t distinguish between possession of misoprostol for the treatment of stomach ulcers or for gynecological treatment.
By punishing individuals who transport or store the drugs for others, The law can create recent barriers to access for a lot of people, even when it doesn’t criminalize pregnant women who take the pill.
What impact do the laws have on other states?
The Supreme Court has interpreted the structure as if each the federal government and states regulate controlled substances. This implies that there could also be differences in access to medications from state to state.
However, states generally follow federal planning policies and practices when make their very own drug classifications. A very famous A rare exception to this common practice is cannabis, which has been decriminalized or legalized in lots of states. against federal law.
The immediate impact will affect clinical trials of the 2 drugs in other states that treat patients in Louisiana. Clinical trials of medicine that are usually not controlled substances will be conducted in any state with little or no additional state regulations. Clinical trials of controlled substances are subject to additional regulatory requirements that may add costs and delay development.
The most certainly long-term consequence is that other states will make similar legislative attempts to limit access to medication abortion, particularly in states that unsuccessfully tried to stop access to medical abortion by other means.
image credit : theconversation.com